How does bitter kola work in the body?

Bitter kola contains bioactive compounds including biflavonoids, kolaflavanone, garcinol, and benzophenones. These compounds exhibit antimicrobial and antiviral properties through inhibition of pathogen replication. The biflavonoids contribute to antioxidant activity, while stimulant properties affect the central nervous system. Evidence Level C indicates these mechanisms require further clinical validation.

Does bitter kola interact with any medications?

Bitter kola has stimulant properties that may interact with medications affecting heart rate and blood pressure, including beta-blockers and antihypertensives. Due to its caffeine-like effects, it may potentiate other stimulants and should be avoided when taking medications for heart conditions. Consult a healthcare provider before combining with prescription medications. Evidence Level C.

What is the recommended daily dosage of bitter kola?

The traditional adult dosage is 2-3 seeds chewed daily, or approximately 500mg of standardized extract. Seeds should be chewed thoroughly to release active compounds. This dosing is based on traditional use and limited clinical evidence (Level C). Individual tolerance varies, and users should start with lower amounts to assess response.

Is bitter kola safe to take during pregnancy?

Bitter kola is considered unsafe during pregnancy. The seeds contain stimulant compounds that may cause uterine contractions, increased heart rate, and elevated blood pressure. These effects pose potential risks to fetal development and pregnancy maintenance. Women who are pregnant or breastfeeding should avoid bitter kola entirely. Evidence Level C.

What is bitter kola used for traditionally?

Bitter kola has been used traditionally by Yoruba and Igbo peoples in West Africa for treating coughs and respiratory conditions, as a digestive stimulant, and as a male vitality tonic. Modern research has identified antimicrobial and antiviral properties, supporting some traditional applications. Evidence Level C indicates more clinical studies are needed to confirm efficacy.

What are the side effects of bitter kola?

Common side effects include insomnia, heart palpitations, and stimulant-related symptoms such as nervousness and increased alertness. These effects result from the seed's bioactive compounds. Individuals with heart conditions, anxiety disorders, or sleep difficulties should avoid bitter kola. Side effects typically resolve after discontinuation. Evidence Level C.

Nigerian Bitter Kola (Garcinia kola)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Garcinia kola, commonly known as bitter kola, is a medicinal plant indigenous to West and Central Africa used traditionally to treat various inflammatory and infectious diseases [PMID: 35528115, 37359709].

Contexte

Garcinia kola belongs to the Garcinia genus of the Clusiaceae family and Malpighiales order, with over 180 members globally, primarily found in Asia and tropical African countries [PMID: 35528115]. It is a tree indigenous to West and Central Africa where all plant parts, especially the seeds, are valued in local folklore medicine [PMID: 37359709].

Usages traditionnels

Traditionally used in Africa to manage cancer, diabetes, malaria, hypertension, analgesia [PMID: 35528115], as well as diarrhea, bronchitis, bacterial infections, cough, hepatitis, gonorrhea, laryngitis, food poisoning, liver and gastric diseases [PMID: 34904497], and to induce stimulating and aphrodisiac effects [PMID: 37359709].

Composés actifs

Key compounds include Kolaviron (a biflavonoid) [PMID: 33185157], garcinoic acid (a vitamin E derivative) [PMID: 30897408], and various other biflavonoids, benzophenones (such as gakolanone and kolaflavanone), benzofurans, benzopyran, xanthones, and phytosterols [PMID: 37359709, 34904497].

Mécanisme d'action

Mechanisms include antioxidant and anti-inflammatory activities [PMID: 33185157, 37495834], inhibition of oxidative stress and inflammatory responses via the SREBP-1c pathway in liver injury [PMID: 40666176], and regulation of PPARα and SIRT6 to improve lipid metabolism and reduce apoptosis in HepG2 cells [PMID: 35335339]. Garcinoic acid has been shown to diminish the upregulation of iNos and Cox2 expression [PMID: 30897408].

Preuves cliniques

Preuve BIntraocular Pressure

Oral ingestion of G. kola (100 mg/kg) lowered intraocular pressure in healthy subjects [PMID: 32275352].

Preuve BKnee Osteoarthritis

Clinical effects were assessed in a randomized, placebo-controlled, double-blind trial using 200 mg doses [PMID: 18667082].

Preuve BBronchoconstriction

Consumption of 15g of G. kola showed a significant time-dependent increase in peak expiratory flow rate (PEFR) at 60 minutes, suggesting a mild bronchodilator effect [PMID: 8261939].

Preuve DDiabetes/NAFLD

Ethanol extract significantly reduced blood glucose and improved lipid accumulation and oxidative stress in diabetic rat models [PMID: 40666176].

Preuve DCardiotoxicity

Kolaviron and G. kola attenuated doxorubicin-induced cardiotoxicity in Wistar rats [PMID: 28972943].

Preuve DCognitive Impairment

Kolaviron (100 mg/kg) reduced memory deficits and hippocampal levels of caspases 1, 3, and TNFα in okadaic acid-induced rat models [PMID: 38356522].

Sécurité et effets indésirables

No specific adverse effects are detailed in the provided abstracts, though the plant is noted as a safe alternative to synthetic compounds in the context of enzymatic hydrolysates [PMID: 37495834].

Interactions médicamenteuses

Concurrent administration of G. kola with quinine reduced the tmax of quinine by 48%, and reduced mean Cmax and AUC of quinine and its metabolite 3-hydroxyquinine [PMID: 25328082].

Synthèse des preuves

Evidence consists primarily of animal models (D) and review articles (C), with a few small-scale human clinical trials (B) regarding ocular pressure, bronchodilation, and osteoarthritis.

Sources PubMed

1.PMID: 35528115 (2022) — Biological Evaluation of Garcinia kola Heckel. · Advances in pharmacological and pharmaceutical sciences
2.PMID: 33185157 (2021) — Kolaviron: A Biflavonoid with Numerous Health Benefits. · Current pharmaceutical design
3.PMID: 32275352 (2020) — Oral consumption of Garcinia kola(Bitter kola) lowers intraocular pressure. · Acta ophthalmologica
4.PMID: 34904497 (2022) — A review on garcinia kola heckel: traditional uses, phytochemistry, pharmacological activities, and toxicology. · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
5.PMID: 37954367 (2023) — Antioxidant activity and efficacy of Garcinia kola (bitter kola) oil on pathogenic and alteration microorganisms of attiéké.

Nigerian Bitter Kola

Sources et citations

Illicium verum

Fortunella japonica

Ceterach Officinarum

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Nigerian Bitter Kola

Sources et citations

Plantes associées

Illicium verum

Fortunella japonica

Ceterach Officinarum

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales